← Back to Search

Vestibular Balance Therapy for Vestibular Disorders (VBT-C Trial)

N/A
Recruiting
Led By Jennifer B Christy, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Confirmed diagnosis of severe to profound SNHL
Age 6-12 years
Must not have
Currently receiving vestibular therapy
Neurologic condition other than SNHL
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study period at 2 years

Summary

This trial tests a home-based balance therapy for children with hearing loss and balance issues. The program involves specific exercises done at home with regular therapist check-ins. It aims to see if the therapy is practical and beneficial for improving balance and coordination.

Who is the study for?
This trial is for children aged 6-12 with severe to profound sensorineural hearing loss (SNHL) who can commit, along with their caregiver, to an 8-week home-based vestibular balance therapy program. They must have had a vision test within the last year or be willing to undergo one. Children with other neurological conditions, poor reading or picture identification skills, current vestibular therapy, or uncorrected vision issues are not eligible.
What is being tested?
The study tests a home-based vestibular balance therapy designed for children with vestibular hypofunction. Over eight weeks, participants will perform exercises five times per week and have weekly check-ins with a physical therapist. The aim is to assess the feasibility of this program and its preliminary impact on function before planning a larger trial.
What are the potential side effects?
Since this intervention involves physical exercises at home under supervision rather than medication, side effects may include dizziness or imbalance during initial sessions but should improve as therapy progresses.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with severe to profound hearing loss.
Select...
I am between 6 and 12 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently undergoing therapy for balance issues.
Select...
I have a neurological condition that is not sensorineural hearing loss.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study period at 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study period at 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Computerized Dynamic Visual Acuity at 4 and 8 weeks
Change in Functional Gait Assessment at 4 and 8 weeks
Change in Sensory Organization Test at 4 and 8 weeks
Secondary study objectives
Management Feasibility (data entry)
Management Feasibility (training)
Participant Experience Feasibility (Enjoyment)
+10 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: VBP Intervention GroupExperimental Treatment1 Intervention
Children coded as abnormal on functional tests (FT) (n=12) will participate in an 8-week 5X/week home-based VBT program. At the initial visit (T0), the PI will instruct the participants (caregiver and child) in the program and provide all materials. The exercises will be led by the caregiver, with weekly in person checks by the PI to progress and provide coaching. The child/caregiver will complete a daily log to report activities and level of enjoyment. VBT will be done 5 days/week and will include 4 key categories of exercises, each lasting 5 minutes (20 minutes total of exercise per day). The 4 categories, explained below, include: 1) Times 1 (X1) Viewing, 2) Gaze Shifting, 3) Static Balance, 4) Dynamic Balance. The proposed VBT home program will include 10 minutes of gaze stabilization exercises, and 10 minutes of balance training.
Group II: Sham InterventionPlacebo Group1 Intervention
Sham Intervention (not to be compared to intervention - for feasibility only): Aim 1 is to establish the feasibility of a control intervention to be used in future studies. Therefore, 3 participants who score above the set criterion for the Functional Tests (FT) (i.e., they do not need VBT) will participate in an 8-week sham intervention. At T0, the PI will instruct the participants to do the sham intervention, led by the caregiver with weekly checks to control for attention bias. The sham intervention will be done for 20 minutes per day and will consist of 10 minutes of focused reading a book of the child's choice and 10 minutes of active play. The child and caregiver will complete a daily activity log documenting the activity and level of enjoyment.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The home-based vestibular balance therapy program for Bilateral Vestibulopathy focuses on improving balance and vestibular function through targeted exercises. These exercises typically include gaze stabilization, balance training, and habituation exercises. Gaze stabilization exercises help improve the control of eye movements, which is crucial for maintaining clear vision during head movements. Balance training enhances the body's ability to maintain stability and prevent falls by strengthening the muscles and improving coordination. Habituation exercises reduce dizziness by gradually exposing patients to movements that provoke their symptoms, thereby desensitizing their vestibular system. These mechanisms are vital for Bilateral Vestibulopathy patients as they help compensate for the loss of vestibular function, improve daily functioning, and enhance overall quality of life.
Manual therapy with and without vestibular rehabilitation for cervicogenic dizziness: a systematic review.

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,645 Previous Clinical Trials
2,342,837 Total Patients Enrolled
Foundation for Physical Therapy ResearchUNKNOWN
1 Previous Clinical Trials
1,441 Total Patients Enrolled
Jennifer B Christy, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham

Media Library

Vestibular Balance Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05741515 — N/A
Bilateral Vestibulopathy Research Study Groups: VBP Intervention Group, Sham Intervention
Bilateral Vestibulopathy Clinical Trial 2023: Vestibular Balance Therapy Highlights & Side Effects. Trial Name: NCT05741515 — N/A
Vestibular Balance Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05741515 — N/A
~0 spots leftby Dec 2024